We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.
Click here for more information on cookies, including how to remove them.
Enrolled participants will receive details by email when an EQA is open for assessment and/or samples have been dispatched.
Participants are expected to access the instructions and information for the cases/samples online and to analyse them according to their laboratory/centre protocols.
Participants must submit their anonymised results by the deadline using their standard laboratory report and an online proforma provided by GenQA. The submitted results are independently assessed for the accuracy of the analytical/genotyping and interpretation of results.
What can I expect as a participant?
Every participant will receive:
An Individual Laboratory/Centre Report (ILR/ICR) with educational advice for each distribution of this EQA.
The Summary report for each distribution of this EQA which contains information regarding general findings, a summary of methodologies used, common errors, number of participants and benchmarking.
Access to a live Performance Certificate summarising your performance status for all EQAs in which you are enrolled.
Please note: EQA details may be subject to change prior to EQA distribution.
PRODUCTS
Sample type: DNA in TE buffer
Testing/analysis: Test any pharmacogenomic genes/variants.
Two DNA sample cases will be provided.
An optional educational case focused on cardiac pharmacogenomics will be available for interpretation only.
Conditions/Gene target(s):The following genes will be assessed, with the focus on AMP Tier 1 and/or Tier 2 recommended variants (where applicable). For other genes, the 'common' variants will be included. Please contact info@genqa.org for specific details.
NEWSLETTER SIGN UP